Bristol Myers Squibb has reported disappointing results for its checkpoint inhibitor combination Opdualag in melanoma, dashing its hopes of moving the drug earlier in the treatment pathway.

Zero-overhead data marshalling protocol for safety-critical distributed systems with NASA-STD-8739.8 compliance, formal verification, and Zero Trust architecture.

Support for digital signatures, which provide authentication of data using public-key cryptography. All algorithms reside in the separate crates and implemented using traits from the signature crate.